FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
VelosBio
VelosBio Inc. is a near-term clinical-stage biopharmaceutical company focused on novel cancer targets.
